【レポートの概要（一部）】
1. Report Overview
1.1 Gastric Cancer Therapeutics: Market Overview
1.2 Global Gastric Cancer Therapeutics Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Main Questions Answered by This Analytical Study
1.6 Who is This Report For?
1.7 Methods of Research and Analysis
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to Gastric Cancer Treatment
2.1 Stomach Cancer: An Overview
2.2 Treatments for Stomach Cancer
2.3 Defining the Gastric Cancer Therapies Market
3. Leading Stomach Cancer Drugs
3.1 Herceptin (trastuzumab) – Roche: The First Targeted Drug Approved as a Gastric Cancer Treatment
3.1.1 Herceptin: Treatment of HER2+ Cancer
3.1.2 Herceptin: Method of Administration and Side Effects
3.1.3 ToGA: Pivotal Herceptin Study Led to Approvals
3.1.4 ToGA Trial Results
3.1.4.1 Further Possibilities from the ToGA Results
3.1.5 Herceptin Revenue Forecast 2015-2026: Losing Battle with Biosimilar Trastuzumab
3.2 Cyramza (ramucirumab) – Eli Lilly
3.2.1 REGARD and RAINBOW: Pivotal Cyramza Clinical Trials
3.2.2 Cyramza: VEGF Targeting for the Inhibition of Angiogenesis
3.2.3 Cyramza’s Development: Potential as a Combination Treatment
3.2.4 Cyramza Revenue Forecast 2015-2026
3.3 Taxotere (docetaxel) – Sanofi
3.3.1 Taxotere Revenue Forecast 2015-2026
3.4 Xeloda (capecitabine) – Roche
3.4.1 Xeloda Revenue Forecast 2015-2026
3.5 Abraxane (paclitaxel protein-bound particles) – Celgene/ Taiho Pharmaceutical/Otsuka Pharmaceutical
3.5.1 Abraxane Revenue Forecast 2015-2026
3.6 TS-1 (S-1/Teysuno) – Taiho Pharmaceutical/Otsuka Pharmaceutical
3.6.1 TS-1 Revenue Forecast 2015-2026
3.7 Apatinib (YN968D1) – Jiangsu Hengrui Medicine/LSK BioPartners/Bukwang Pharmaceutical Company
3.7.1 Apatinib Revenue Forecast 2015-2026
4. The Gastric Cancer Treatment R&D Pipeline Analysis 2016-2026
4.1 The Importance of R&D in the Gastric Cancer Treatment Industry
4.2 Perjeta (pertuzumab) – Roche – A Novel HER2 Targeting Mechanism
4.3 Opdivo (nivolumab/ONO-4538) – Bristol-Myers Squibb
4.4 Keytruda (pembrolizumab/MK3475) – Merck/MSD
4.5 TAS-118 – Taiho Pharmaceutical/Otsuka Pharmaceuticals
4.6 TAS-102 – Taiho Pharmaceutical/Otsuka Pharmaceuticals/Servier
4.7 NeuVax (nelipepimut-S) – Galena Biopharma/Dr. Reddy’s Laboratories
4.8 Ipatasertib (GDC-0068/RG7440) – Genentech/Roche/Array BioPharma
4.9 Durvalumab (MEDI4736) – AstraZeneca/MedImmune
4.10 Avelumab- (MSB0010718C) – Merck KGaA/Pfizer
4.11 Claudiximab (IMAB362) – Ganymed Pharmaceutical
4.12 Napabucasin (BBI608) – Boston Biomedical
4.13 AZD4547 – AstraZeneca
4.14 Dovitinib (TKI258) – Novartis
4.15 The Future of the Gastric Cancer Treatment Landscape: Other Compounds of Future Interest
5. Global Gastric Cancer World Market 2015 to 2026: Forecasts and SWOT Analysis
5.1 The Global Gastric Cancer Treatment Market Forecast 2015-2026
5.2 World Revenue Forecasts 2015-2026: Changing Market Shares for the Gastric Cancer Treatment Market
5.3 Chemotherapy Segment Forecast, 2015-2026
5.4 Monoclonal Antibodies Segment Forecast, 2015-2026
5.5 Angiogenesis Inhibitors Segment Forecast, 2015-2026
5.6 Drivers and Restraints of the Gastric Cancer Treatment Market 2015 to 2026
5.6.1 Factors Driving Growth in the Gastric Cancer Treatment Market 2015 to 2026
5.6.1.1 A Rise in the At-Risk Population Will Drive Growth
5.6.1.2 Premium-Pricing of Drugs Will Generate Revenue
5.6.1.3 There is High Unmet Need for Novel Treatments to Improve Poor Prognosis
5.6.1.4 Biomarker Development is Critical to Improving Diagnosis and Prognosis of Gastric Cancer
5.6.1.5 Combination Therapies: Lowering Associated Toxicities and Improving the Safety Profile for Treatments
5.6.2 Factors Restraining the Gastric Cancer Treatment Market 2015 to 2026
5.6.2.1 Loss of Patent Protection Will Open the Market to Generic and Biosimilar Erosion
5.6.2.2 Affordability of Treatment Will Restrain Market Growth Because of Healthcare Budgets
5.6.2.3 Patients are Developing Resistance to Treatment
5.7 SWOT Analysis of the Gastric Cancer Treatment Market 2015 to 2026
6. Leading National Markets for the Gastric Cancer Treatment Market 2015-2026
6.1 Regional Breakdown of the World Gastric Cancer Treatment Market
6.2 World Gastric Cancer Treatment Market: Regional Forecasts 2015-2026
6.2.1 How Will Regional Market Shares Change to 2026?
6.3 The US Gastric Cancer Treatment Market 2015 to 2026
6.4 The EU5 Gastric Cancer Treatment Market 2015 to 2026
6.4.1 The Gastric Cancer Treatment Market in Germany to 2026
6.4.2 The Gastric Cancer Treatment Market in Italy to 2026
6.4.3 The Gastric Cancer Treatment Market in Spain to 2026
6.4.4 The Gastric Cancer Treatment Market in France to 2026
6.4.5 The Gastric Cancer Treatment Market in UK to 2026
6.5 The Japanese Gastric Cancer Treatment Market 2015-2026
6.6 The Gastric Cancer Treatment Market in the Emerging Market: BRIC Market Forecast 2015-2026
6.6.1 The Gastric Cancer Treatment Market in China to 2026
6.6.2 The Gastric Cancer Treatment Market in Brazil to 2026
6.6.3 The Gastric Cancer Treatment Market in Russia to 2026
6.6.4 The Gastric Cancer Treatment Market in India to 2026
7. Research Interview
7.1 Interview with Dr Jun Cai, MD, PhD, Senior Research Fellow, Cardiff China Research Collaborative, Cardiff University, Cardiff, Wales, UK
7.1.1 Biomarkers: An Opportunity in Gastric Cancer Treatment
7.1.2 Challenges in Developing Gastric Cancer Treatments
7.1.3 The Benefits of Using Biomarkers
7.1.4 Targeted Treatment: VEGF Inhibitors
8. Conclusions
8.1 The World Gastric Cancer Treatment Market in 2015
8.2 Market Share Distribution Will Differ Over the Forecast Period
8.3 Leading Gastric Cancer Treatment Drug Companies
8.4 National Market Segments: Changes in Market Share Over the Forecast Period
8.5 Concluding Remarks: The Future of the Gastric Cancer Treatment Market
【レポート販売概要】
■ タイトル：胃がん治療薬の世界市場：研究開発、市場動向、予測■ 英文：Gastric Cancer Drugs - R&D, Trends and Market Forecasts 2016-2026
■ 発行日：2016年6月
■ 調査会社：visiongain
■ 商品コード：VGAIN60708
■ 調査対象地域：グローバル
- Hess Corporation：石油・ガスバリューチェーン分析レポート2013Hess Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Hess Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Hess Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the com …
- 2014年戦略提言：スペインの免疫タンパク質検査市場This new 236-page report from Venture Planning Group provides analysis of the Spanish immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by market segment for the follow assays:C3C4Free Light ChainsHaptoglobinIgAIgE Specific I …
- グローバルにおける乳癌治療市場（2014-2018）About Breast Cancer Breast cancer is characterized by the uncontrolled growth of cancerous cells in the breast tissue. It occurs in both males and females; however, male breast cancer is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer and other undifferentiated carcinoma. Ductal carcinoma is the form of breast cancer which starts in the …
- 世界の感染症検査市場This report provides a worldwide overview of the infectious disease testing market environment, structure, size and growth. The report includes estimates of the number of laboratories performing infectious disease tests, as well as test volume and sales forecasts by country. The report also presents strategic profiles of leading market players and emerging suppliers with inn …
- 2014年戦略提言：フランスの微生物検査市場Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,300. “2014 Strategies for the French Microbiology Testing Market” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key French market trends; reviews current and emerging assays; …
- グローバルにおける女性医療（リプロダクティブ・ヘルス）市場（2014-2018）About Women’s Health Women experience physiological and emotional issues during different phases of their life cycle due to hormonal changes. Women's health is especially referred to where reproductive health is involved. According to the Society for Women's Health Research in the US, issues specific to the human female anatomy are defined as women's health. The biological mechanisms influence the …
- 血液癌治療の世界市場2019-2023About this market Leukemia is the most common type of cancer in children and also accounts for the highest mortality rate among cancers in pediatric patients. The prevalence of leukemia has been increasing at a significantly high rate. The incidence of other types of blood cancer such as lymphomas is also another factor driving the growth of the market, as it is leading to vendors conducting resea …
- U.S. Energy Corp.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013U.S. Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary U.S. Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
- エンジニアリングサービスアウトソーシング（ESO）の世界市場分析The Global engineering services outsourcing (ESO) market is expected to reach USD 1.49 trillion by 2025, according to a new report by Grand View Research, Inc. ESO providers play a crucial role in providing mechanical, technical, and software support to their clients. Due to the growing complexity of product designing, prototyping, visual designing and engineering, and Product Lifecycle Management …
- 医療分野における放射線診療用検知装置の世界市場Medical/healthcare is an established end-market for radiation detection equipment in many applications, and continues to drive improvements in and demand for radiology diagnostic systems. Radiography is one of the most important aspects of non-destructive testing (NDT), and is used in a wide variety of medical applications. The market for detectors has benefited from advancements in the science of …
- 産業用絶縁材の世界市場予測（～2024年）“The industrial insulation market is projected to register a CAGR of 5.0%, in terms of value, between 2019 and 2024.” The industrial insulation market is projected to grow from USD 2.6 billion in 2019 to USD 3.3 billion by 2024, at a CAGR of 5.0%. The increasing demand for electricity owing to rapid urbanization, growing population, and rising requirements of power & energy in emerging economies a …
- 双極性障害市場：アメリカの治療薬市場Bipolar Disorder - US Drug Forecast and Market Analysis to 2024 Summary Bipolar disorder is a mental disorder characterized by periods of mania and depression. The frequency, severity, and pattern of these episodes can vary considerably over time and between individuals, making bipolar disorder one of the most challenging psychiatric disorders to manage. The bipolar disorder market is widely gener …
- エポキシ樹脂の世界市場：インサイト、市場機会、市場シェア、市場予測The global epoxy resins market is estimated to reach $12.15 billion by 2022 and is expected to grow at CAGR of 9.6% during 2016-2022. The Epoxy resins market is segmented on the basis of application and geography. The application segment is further segmented into adhesives, composites, construction, electrical & electronics, other applications, paints & coatings, wind turbine. The composites mater …
- 故障解析装置のグローバル市場（2014-2018）About Failure Analysis Equipment Failure analysis is the engineering process of analyzing the cause of equipment failure by physical and chemical techniques. Failure analysis equipment is used in the Manufacturing industry primarily for new product development and to improve the quality of existing products. This equipment is used to find the root cause of failure and prevent its reoccurrence. Com …
- モバイル決済：旅行者、銀行口座ない人、無/低信用者（Mobile Payments: The Market for Travelers, Unbanked, and No/Low Credit Users）A significant portion of the global population is “unbanked”, low credit, or otherwise unable to establish and maintain a bank account. While this portion of the population is on a downtrend due to globalization and developing countries becoming more industrialized, the market segment without a traditional financial account is an important market segment for mobile commerce. In addition, travelers …
